๐ฃ๐๐๐๐ถ๐ป๐ด ๐ฃ๐ต๐ฎ๐ด๐ฒ ๐๐ผ ๐ช๐ผ๐ฟ๐ธ โ Some Interspecies Immunology
Our newest investment just went public today. Sensei Bio reengineers the lambda bacteriophage to expose the unique antigen signatures of tough human cancers. The viral capsid is both a cheaply-manufactured nanoparticle and a natural adjuvant for a complete and safe vaccine (the phage cannot infect human cells and are inactivated). They are currently in Phase 2 clinical trials for Head and Neck Cancer and have shown broader applicability for infectious diseases.
Looking like badass alien landers ready to give a genetic probe, phage are incredible workhorses in the natural world โ killing half of all bacteria on Earth every 48 hours! Their rapid replication cycle in bacteria affords inexpensive mass manufacturing.
Company: https://senseibio.com
Today’s news: https://www.businesswire.com/news/home/20201007005938/en/Sensei-Biotherapeutics-Announces-28.5-Million-Financing-To-Advance-Clinical-Pipeline-and-Immunophageโข-Platform-Targeting-Multiple-Cancers
Leave a Reply